1. Home
  2. BDRX vs NVVE Comparison

BDRX vs NVVE Comparison

Compare BDRX & NVVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDRX
  • NVVE
  • Stock Information
  • Founded
  • BDRX 2000
  • NVVE 1996
  • Country
  • BDRX United Kingdom
  • NVVE United States
  • Employees
  • BDRX N/A
  • NVVE N/A
  • Industry
  • BDRX Biotechnology: Pharmaceutical Preparations
  • NVVE Oil Refining/Marketing
  • Sector
  • BDRX Health Care
  • NVVE Energy
  • Exchange
  • BDRX Nasdaq
  • NVVE Nasdaq
  • Market Cap
  • BDRX 3.9M
  • NVVE 4.2M
  • IPO Year
  • BDRX N/A
  • NVVE N/A
  • Fundamental
  • Price
  • BDRX $6.41
  • NVVE $0.25
  • Analyst Decision
  • BDRX
  • NVVE
  • Analyst Count
  • BDRX 0
  • NVVE 0
  • Target Price
  • BDRX N/A
  • NVVE N/A
  • AVG Volume (30 Days)
  • BDRX 54.6K
  • NVVE 5.3M
  • Earning Date
  • BDRX 09-23-2025
  • NVVE 11-11-2025
  • Dividend Yield
  • BDRX N/A
  • NVVE N/A
  • EPS Growth
  • BDRX N/A
  • NVVE N/A
  • EPS
  • BDRX N/A
  • NVVE N/A
  • Revenue
  • BDRX N/A
  • NVVE $4,949,747.00
  • Revenue This Year
  • BDRX N/A
  • NVVE $892.33
  • Revenue Next Year
  • BDRX N/A
  • NVVE N/A
  • P/E Ratio
  • BDRX N/A
  • NVVE N/A
  • Revenue Growth
  • BDRX N/A
  • NVVE N/A
  • 52 Week Low
  • BDRX $5.00
  • NVVE $0.18
  • 52 Week High
  • BDRX $108.90
  • NVVE $8.76
  • Technical
  • Relative Strength Index (RSI)
  • BDRX 52.55
  • NVVE 32.59
  • Support Level
  • BDRX $6.14
  • NVVE $0.24
  • Resistance Level
  • BDRX $7.09
  • NVVE $0.27
  • Average True Range (ATR)
  • BDRX 0.52
  • NVVE 0.05
  • MACD
  • BDRX 0.18
  • NVVE 0.01
  • Stochastic Oscillator
  • BDRX 73.54
  • NVVE 33.55

About BDRX Biodexa Pharmaceuticals plc

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

About NVVE Nuvve Holding Corp.

Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.

Share on Social Networks: